Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 198412, 6 pages
http://dx.doi.org/10.1155/2012/198412
Clinical Study

Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series

1Division of Medical Oncology C, Centro di Riferimento Oncologico, 33081 Aviano, Italy
2Epidemiology Unit, Centro di Riferimento Oncologico, 33081 Aviano, Italy
3Clinical Trial Office, Centro di Riferimento Oncologico, 33081 Aviano, Italy
4Pharmacy Unit, Centro di Riferimento Oncologico, 33081, Aviano, Italy

Received 26 October 2011; Revised 5 January 2012; Accepted 20 January 2012

Academic Editor: Bruno Vincenzi

Copyright © 2012 Vincenzo Di Lauro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Vincenzo Di Lauro, Elena Torrisi, Ettore Bidoli, Daniela Quitadamo, Sara Cecco, and Andrea Veronesi, “Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series,” Journal of Oncology, vol. 2012, Article ID 198412, 6 pages, 2012. https://doi.org/10.1155/2012/198412.